RxDoctor Payments Data

Stewart Williams, MD

Family Medicine · Valdosta, GANPI 1437231255

Payments from drug & device makers

$112in general payments, 2019–2025

Across 6 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$27
  • Amgen$24
  • Abbott$16
  • AstraZeneca$16
  • Adlon Therapeutics L.p.$15
  • Lilly USA, LLC$14

What the payments were for

  • Food & beverage$112100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer1$27
Amgen1$24
Abbott1$16
AstraZeneca1$16
Adlon Therapeutics L.p.1$15
Lilly USA, LLC1$14

How this compares

$112 in reported general payments places this provider in the 20th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$309,065
Medicare patients
692
Services billed
9,663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban126$110,313
OzempicSemaglutide65$84,164
MounjaroTirzepatide63$81,153
ShingrixVaricella-Zoster Ge/As01b/Pf141$31,357
RybelsusSemaglutide27$31,255
FarxigaDapagliflozin Propanediol26$21,079
MyrbetriqMirabegron27$15,352
XareltoRivaroxaban20$14,848
JardianceEmpagliflozin13$13,417
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$12,749
Tresiba Flextouch U-100Insulin Degludec25$12,723
Repatha SyringeEvolocumab16$10,961
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$6,913
SymbicortBudesonide/Formoterol Fumarate21$6,153
JentaduetoLinagliptin/Metformin Hcl11$5,622

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$110,313126 claims
Lilly USA, LLCMounjaro$14$81,15363 claims
AstraZenecaFarxiga, Symbicort, Bevespi Aerosphere$16$31,96358 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Valdosta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →